期刊文献+

食管鳞癌clusterin表达及其临床意义 被引量:1

Clinical significance of clusterin expression in esophageal squamous cell carcinoma
下载PDF
导出
摘要 目的:探讨食管鳞癌组织clusterin表达和单纯手术治疗前后外周血clusterin含量变化与食管鳞癌临床参数的相关性.方法:RT-PCR分析5对食管鳞癌及其远端切缘食管上皮中clusterin基因mRNA表达水平;ELISA分析41例单纯手术治疗食管鳞癌患者治疗前后的血清clusterin蛋白表达水平及其与临床特征的相关性.结果:与正常食管上皮相比食管鳞癌组织中clusterin基因表达显著下降或缺失.食管鳞癌患者术前血清中clusterin含量明显低于术后血清含量(3.23mg/Lvs25.71mg/L,P<0.0001).食管鳞癌患者术前血清clusterin含量与肿瘤大小相关(P<0.01),而与年龄、性别、分化程度、肿瘤分期、淋巴结转移,以及总蛋白、白蛋白、血糖、血脂和总胆红素浓度无关(r=-0.1334,-0.1602,0.2413,0.0389,-0.2882,均P>0.05).结论:Clusterin基因在食管鳞癌组织中表达明显下调或缺失,血清clusterin含量明显降低,提示在食管鳞状细胞癌中clusterin基因可能具有潜在的抑癌基因作用,动态检测外周血clusterin含量有助于判断食管癌进展. AIM:To investigate the expression of clusterin mRNA in esophageal squamous cell carcinoma (ESCC),measure preoperative and postoperative serum clusterin protein levels in ESCC patients,and evaluate their correlations with clinicopathological parameters in ESCC.METHODS:The expression of full-length clusterin mRNA in ESCC tissue was detected by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR).Serum clusterin level was measured by enzyme-linked immunosorbent assay (ELISA).RESULTS:The expression of clusterin mRNA was significantly down-regulated in ESCC tissue compared with matched tumor-adjacent noncancerous tissue.The median level of serum clusterin in postoperative ESCC patients was significantly higher than that in preoperative patients (25.71 mg/L vs 3.23 mg/L,P〈 0.0001).The level of serum clusterin is correlated with tumor size,but not with age,gender,tumor differentiation,tumor grade,lymph node metastasis and biochemical parameters.CONCLUSION:The expression of clusterin mRNA is down-regulated in ESCC.Serum clusterin level decreases in ESCC patients.Clusterin might be a potential tumor suppressor gene in ESCC.Dynamic measurement of serum clusterin level might aid to evaluate the progression of ESCC.
出处 《世界华人消化杂志》 CAS 北大核心 2010年第12期1217-1221,共5页 World Chinese Journal of Digestology
基金 国家高技术发展计划"863"基金资助项目 No.2008DFA31130 国家高技术发展计划"863"基金资助项目 No.2006AA02A403 国家自然科学基金资助项目 No.30721001 国家自然科学基金资助项目 No.30772507~~
关键词 食管鳞状细胞癌 CLUSTERIN 双向电泳 Esophageal squamous cell carcinoma Clusterin Two-dimensional eletrophoresis
  • 相关文献

参考文献3

二级参考文献14

  • 1Laurent Puig P, Legoix P, Bluteau O, et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepoatocarcinogenesis. Gastroenterology, 2001, 120: 1763-1773.
  • 2Bergsland EK. Molecular mechanisms underlying the development of hepatocellular carcinoma. Semin Oncol, 2001, 28: 521-531.
  • 3Li QL, Ito K, Sakaura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell, 2002, 109:113-124.
  • 4Fang W, Piao Z, Simon D, et al. Mapping of a minimal deleted region in human hepatocellular carcinoma to l p36.13-p36.33 and mutational analysis of the RIZ (PRDM2) gene localized to the region.Genes Chromosomes Cancer, 2000, 28: 269-275.
  • 5Zaidi SK, Sullivon AJ, Wijnen AJV, et al. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites.Proc Natl Acad Sci, 2002, 99: 8048-8053.
  • 6Song BC, Chung YH, Kim JA, et al. Transforming growth factorbetal as a useful serologic marker of small hepatocellular carcinoma.Cancer, 2002, 94: 175-180.
  • 7Matuzaki K, Date M, Furukawa F, et al. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellalar carcinoma: implications for roles of smads in its growth.Hepatology, 2000, 32: 218-227.
  • 8肖文华,刘为纹,吕有勇,高崇峰.肝细胞癌多种抑癌基因失活机理的研究[J].第三军医大学学报,1997,19(4):324-328. 被引量:10
  • 9肖文华,刘为纹,吕有勇,高崇峰.Rb基因在肝细胞癌中的多种失活机制[J].中华肝脏病杂志,1997,5(3):142-144. 被引量:4
  • 10李峰,关勇军,陈主初.蛋白质组学及其在肿瘤研究中的应用[J].生物化学与生物物理进展,2001,28(2):164-167. 被引量:6

共引文献50

同被引文献32

  • 1林晓燕,张叔人,徐恒.真核生物DNA聚合酶δ的研究现状[J].自然科学进展,2005,15(1):1-7. 被引量:5
  • 2Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
  • 3Yuen MF, Hou JL, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol 2009; 24: 346-353.
  • 4W?rns MA, Galle PR. Future perspectives in hepatocellular carcinoma. Dig Liver Dis 2010; 42 Suppl 3: S302-S309.
  • 5Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010; 29: 4989-5005.
  • 6Hindges R, Hübscher U. DNA polymerase delta, an essential enzyme for DNA transactions. Biol Chem 1997; 378: 345-362 .
  • 7Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
  • 8Shevelev IV, Hübscher U. The 3' 5' exonucleases. Nat Rev Mol Cell Biol 2002; 3: 364-376.
  • 9Tyson JJ, Novak B. Temporal organization of the cell cycle. Curr Biol 2008; 18: R759-R768.
  • 10Sclafani RA, Holzen TM. Cell cycle regulation of DNA replication. Annu Rev Genet 2007; 41: 237-280.

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部